LANDONI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 9.866
EU - Europa 4.389
AS - Asia 3.761
SA - Sud America 534
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 18.614
Nazione #
US - Stati Uniti d'America 9.667
SG - Singapore 1.313
CN - Cina 1.254
IT - Italia 936
SE - Svezia 701
RU - Federazione Russa 654
HK - Hong Kong 630
DE - Germania 513
IE - Irlanda 471
BR - Brasile 457
UA - Ucraina 436
GB - Regno Unito 251
VN - Vietnam 189
CA - Canada 164
FI - Finlandia 114
FR - Francia 113
KR - Corea 105
IN - India 58
NL - Olanda 40
BD - Bangladesh 39
TR - Turchia 37
AT - Austria 32
DK - Danimarca 30
AR - Argentina 29
MX - Messico 28
PL - Polonia 27
ZA - Sudafrica 24
JP - Giappone 21
BE - Belgio 20
TH - Thailandia 20
ID - Indonesia 18
EC - Ecuador 17
IQ - Iraq 17
CZ - Repubblica Ceca 12
LT - Lituania 9
PK - Pakistan 9
CH - Svizzera 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
ES - Italia 7
IR - Iran 7
VE - Venezuela 7
KE - Kenya 6
CL - Cile 5
EG - Egitto 5
EU - Europa 4
PY - Paraguay 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GE - Georgia 2
GR - Grecia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
SC - Seychelles 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 18.614
Città #
Ann Arbor 1.758
Woodbridge 828
Houston 792
Singapore 733
Fairfield 705
Hong Kong 629
Chandler 588
Ashburn 577
Jacksonville 483
Dublin 449
Wilmington 391
Frankfurt am Main 331
Dearborn 318
Seattle 274
Santa Clara 232
Milan 224
Cambridge 215
New York 212
Beijing 190
Princeton 188
Hefei 184
Nanjing 126
Lissone 110
Dallas 109
Seoul 103
Shanghai 92
Lawrence 89
Los Angeles 87
Altamura 80
Lachine 78
Moscow 61
Buffalo 60
Boardman 58
Ho Chi Minh City 51
Guangzhou 50
São Paulo 47
Chicago 46
Council Bluffs 44
San Diego 37
Shenyang 36
Changsha 34
Dong Ket 33
Nanchang 33
Falls Church 32
London 32
Andover 31
Monza 30
Hanoi 28
Fremont 27
Jinan 27
Vienna 26
Helsinki 24
Mountain View 23
Ottawa 23
Toronto 22
Philadelphia 21
Bangkok 20
Brooklyn 20
Huizen 20
Munich 20
The Dalles 20
Tianjin 19
Brussels 18
Columbus 18
Hebei 18
Rio de Janeiro 18
Zhengzhou 18
Jiaxing 17
Rome 17
Tokyo 17
Porto Alegre 16
Stockholm 16
Montreal 15
Warsaw 15
Paris 14
Spoltore 14
Norwalk 13
Genoa 12
Jakarta 12
Phoenix 12
Redondo Beach 12
Kunming 11
Ningbo 11
Orem 11
Salt Lake City 11
Segrate 11
University Park 11
Elk Grove Village 10
Nuremberg 10
Orzinuovi 10
Pune 10
Amsterdam 9
Brno 9
Da Nang 9
Hangzhou 9
Mexico City 9
Tampa 9
Atlanta 8
Baghdad 8
Belo Horizonte 8
Totale 12.706
Nome #
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 466
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 405
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 394
18F-FDG-PET/CT guiding to diagnosis of neurosarcoidosis 387
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 374
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 370
FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients 345
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 340
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 309
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases 306
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 300
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 283
Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer 260
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 258
Multi-modal medical image integration to optimize radiotherapy planning in lung cancer treatment 257
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 256
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 253
Evaluation of time of flight (TOF) and point spread function (PSF) reconstructions in the quantification of myocardial blood flow with 13N ammonia and PET: Comparison among reconstructions (reprojection, OSEM), software (PMOD and CARIMAS) and operators 248
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases 245
Patients with known or suspected lung cancer: evaluation of clinical management changes due to f-fluorodeoxyglucose positron emission tomography (f-fdg pet) study 242
Role of PET/CT in the clinical management of locally advanced pancreatic cancer 235
C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: An initial experience 234
Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease 230
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation 226
Whole-body scintigraphy with 99Tcm-mibi, 18f-fdg and 131I in patients with metastatic thyroid carcinoma 212
Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients 211
Relation between dobutamine trans-thoracic echocardiography, 99Tcm-MIBI and 18FDG uptake in chronic coronary artery disease 211
Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers 205
Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease 205
[(11)C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging 203
New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer 203
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence 202
Identification and revascularization of hibernating myocardium inangina-free patients with left ventricular dysfunction 199
Mri, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma 198
Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients: Role of free fatty acid and insulin levels 197
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 197
An automatic classification technique for attenuation correction in positron emission tomography 196
Relation between myocardial 18F-FDG uptake in the fasting state and coronary angiography in patients with coronary artery disease 196
Time dependence of residual tissue viability after myocardial infarction assessed by [18F]fluorodeoxyglucose and positron emission tomography 196
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 194
Automatic registration of PET and CT studies for clinical use in thoracic and abdominal conformal radiotherapy 194
Positron emission tomograhy for the assessment of myocardial viability: A sinopsys of methods and indications 193
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 193
Value of integrated PET/CT for lesion localisation in cancer patients: A comparative study 187
Exercise-induced ischemic arrhythmias in patients with previous myocardial infarction: role of perfusion and tissue viability 186
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 186
Inflammatory pseudotumor of mediastinum treated with tomotherapy and monitored with FDG-PET/CT: Case report and literature review 185
Evaluation of the clinical performances of a large Nal(TI) crystal 3D PET scanner 184
Specificity and sensitivity of exercise-induced ST segment elevation for detection of residual viability: comparison with fluorodeoxyglucose and positron emission tomography 180
Erratum: A procedure for wall detection in [18F]FDG positron emission tomography heart studies (European Journal of Nuclear Medicine (1996) 23 (18-24)) 180
Positive [11c]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer 179
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis 178
Multifocal, persistent cardiac uptake of [18-F]-Fluoro-Deoxy-Glucose detected by positron emission tomography in patients with acute myocardial infarction 176
Target volume definition for stereotactic radiotherapy of lung metastases: A comparison between PET/CT and 4D-PET/CT 174
Role of Computed Tomography and 18F-Fluorodeoxyglucose Positron Emission Tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation 174
Spatial registration of echocardiographic and positron emission tomographic heart studies 173
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results 172
Recurrent hepatoblastoma in orthotopic transplanted liver: detection with FDG Positron Emission Tomography 170
A simplified method to integrate metabolic images in stereotactic procedures using a PET/CT scanner 169
Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up 165
Identification of hibernating myocardium: A comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction 163
18-FDG positron emission tomography in the evaluation of malignant pleural diseases - A pilot study 161
Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability 158
Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma 158
Correlation of SPECT and PET cardiac images by a surface matching registration technique 157
New radiopharmaceuticals and imaging of the heart receptors 157
Feasibility of [F-18]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer 154
Automatic integration of PET/CT images for clinical use in radiotherapy 152
Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms? 151
Molecular imaging in prostate cancer: [11C]choline PET/CT 150
Rest distribution of 99mTc-MIBI in patients with coronary artery disease assessed by SPECT: Comparison with the distribution of [18F]FDG assessed by PET 149
Helical tomotherapy for scalp recurrence of primary eccrine mucinous adenocarcinoma 148
Concurrent pheochromocytoma, diabetes insipidus and cerebral venous thrombosis - a possible unique pathophysiological mechanism 147
PET-CT and breast cancer 146
Application of a surface matching image registration technique to the correlation of cardiac studies in positron emission tomography (PET) by transmission images 143
A procedure for patient repositioning and compensation for misalignment between transmission and emission data in PET heart studies 142
Glucose metabolism and pathological findings in uveal melanoma preliminary results 141
Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: relationship to coronary anatomy and ventricular function 141
PET/CT in diagnostic oncology 140
Value of [11C]choline-positron emission tomography for re-staging prostate cancer: A comparison with [18F]fluorodeoxyglucose-positron emission tomography 139
The prognostic power of [11C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification 138
Abnormal myocardial glucose handling in patients with syndrome X: Effect of beta-adrenergic blockade 138
Two dimensional vs three-dimentional imaging in whole boby oncologic PET/CT: A discovery-STE phantom and patient study 132
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 128
Advanced ovarian carcinoma: Usefulness of [18F]FDG-PET in combination with CT for lesion detection after primary treatment 122
Clinical application of 11C-Choline PET in patients with biochemical relapse of prostate cancer 120
Lack of prognostic value of 99mTc MIBI rest, 18F FDG and 201Tl rest/redistribution on PTCA outcome of patients with moderate left ventricle dysfunction 118
PET/CT and breast cancer 116
Increased [11C]Choline uptake in bronchioalveolar cell carcinoma with negative [18F]FDG uptake. A PET/CT and pathology study 111
PET-Guided target delineation in a patient with lung cancer. 106
Rapid spread of PET in workup of cancer - But Sweden lags behind [Snabb ökning av PET i utredning av cancer - Men sverige släpar efter] 105
Regional glucose utilization in infarcted and remote myocardium: Its relation to coronary anatomy and perfusion 103
Ruolo della tomografia ad emissione di positroni nella caratterizzazione dei noduli solitari polmonari indeterminati 103
Correction measured by attenuation in tomographic heart studies with single photon emission with thallium 201. Comparison with positron- emission tomographic studies with ammonium marked with nitrogen 88
Imaging myocardial innervation in congestive heart failure: methods and clinical implications 84
Comparison of dual-head coincidence PET versus ring PET in tumor patients 84
Tomoterapia ed ipofrazionamento 84
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 16
Totale 18.939
Categoria #
all - tutte 64.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.059


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.225 0 0 0 0 151 129 164 169 162 193 103 154
2021/20221.327 90 170 153 145 71 71 74 79 64 74 135 201
2022/20232.265 268 607 174 250 177 367 18 96 163 43 79 23
2023/20241.392 67 54 81 64 192 371 271 36 71 21 29 135
2024/20253.214 176 473 165 138 237 102 131 151 251 432 434 524
2025/20262.890 656 498 532 753 451 0 0 0 0 0 0 0
Totale 18.939